This inventor holds 1 USPTO granted patent. Top assignee: Mor Research Applications Ltd.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Keren Ben-Yaakov: Innovator in Mitochondrial Transplantation for Ocular Diseases
Introduction
Keren Ben-Yaakov is a notable inventor based in Rehovot, Israel. He has made significant contributions to the field of ocular medicine through his innovative research and patents. His work focuses on addressing mitochondrial dysfunction in the eye, which is crucial for treating various ocular diseases.
Latest Patents
Keren Ben-Yaakov holds a patent titled "Mitochondrial transplantation and use thereof in ocular diseases." This patent outlines methods for treating ocular diseases and conditions associated with mitochondrial dysfunction, destruction, and depletion in the eye. The methods involve the transplantation of viable exogenous, isolated mitochondria to ocular tissues. This innovative approach is effective in treating ocular manifestations of diseases, disorders associated with mitochondrial dysfunction, and ocular ischemic insults.
Career Highlights
Keren is associated with Mor Research Applications Ltd., where he continues to advance his research in mitochondrial transplantation. His work has the potential to revolutionize treatment options for patients suffering from various ocular conditions.
Collaborations
Keren collaborates with talented individuals in his field, including Ziv Rotfogel and Michal Simon, who contribute to his research endeavors.
Conclusion
Keren Ben-Yaakov's innovative work in mitochondrial transplantation represents a significant advancement in the treatment of ocular diseases. His contributions are paving the way for new therapeutic strategies that could greatly benefit patients with mitochondrial dysfunction.